Cerner (CERN) Earns In-Line Rating from Analysts at Evercore ISI

Evercore ISI started coverage on shares of Cerner (NASDAQ:CERN) in a research note issued to investors on Thursday, Marketbeat.com reports. The firm set an “in-line” rating and a $77.00 price target on the stock. Evercore ISI’s price target points to a potential upside of 10.81% from the company’s previous close.

CERN has been the subject of a number of other reports. Zacks Investment Research downgraded Cerner from a “buy” rating to a “hold” rating in a report on Thursday, January 4th. Cantor Fitzgerald upped their price objective on Cerner to $83.00 and gave the stock an “overweight” rating in a report on Friday, January 5th. Royal Bank of Canada restated a “buy” rating on shares of Cerner in a report on Wednesday, October 25th. BidaskClub downgraded Cerner from a “buy” rating to a “hold” rating in a report on Friday, December 22nd. Finally, Stifel Nicolaus restated a “hold” rating on shares of Cerner in a report on Wednesday, November 22nd. Seventeen equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $70.21.

Shares of Cerner (NASDAQ CERN) traded down $0.79 on Thursday, reaching $69.49. The company’s stock had a trading volume of 2,434,600 shares, compared to its average volume of 1,698,825. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.77 and a quick ratio of 2.75. The firm has a market cap of $22,870.00, a P/E ratio of 34.57, a PEG ratio of 2.09 and a beta of 0.94. Cerner has a 52 week low of $50.33 and a 52 week high of $73.86.

Cerner (NASDAQ:CERN) last released its quarterly earnings data on Thursday, October 26th. The company reported $0.61 EPS for the quarter, missing analysts’ consensus estimates of $0.62 by ($0.01). The firm had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.29 billion. Cerner had a return on equity of 18.03% and a net margin of 13.37%. The company’s quarterly revenue was up 7.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.59 earnings per share. research analysts anticipate that Cerner will post 2.24 earnings per share for the current year.

In related news, Chairman Clifford W. Illig sold 530,000 shares of the stock in a transaction dated Monday, November 20th. The shares were sold at an average price of $65.54, for a total transaction of $34,736,200.00. Following the sale, the chairman now owns 1,229,719 shares in the company, valued at $80,595,783.26. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Clifford W. Illig sold 140,000 shares of the stock in a transaction dated Thursday, November 16th. The stock was sold at an average price of $65.52, for a total transaction of $9,172,800.00. Following the sale, the chief executive officer now owns 1,229,719 shares in the company, valued at approximately $80,571,188.88. The disclosure for this sale can be found here. In the last quarter, insiders have sold 788,000 shares of company stock worth $52,190,800. 13.11% of the stock is owned by company insiders.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Laurel Wealth Advisors Inc. increased its stake in shares of Cerner by 0.6% in the second quarter. Laurel Wealth Advisors Inc. now owns 3,909 shares of the company’s stock valued at $259,000 after purchasing an additional 24 shares during the period. Advisory Services Network LLC increased its stake in shares of Cerner by 4.4% in the second quarter. Advisory Services Network LLC now owns 1,648 shares of the company’s stock valued at $110,000 after purchasing an additional 70 shares during the period. EagleClaw Capital Managment LLC increased its stake in shares of Cerner by 0.4% in the second quarter. EagleClaw Capital Managment LLC now owns 26,050 shares of the company’s stock valued at $1,734,000 after purchasing an additional 100 shares during the period. Gyroscope Capital Management Group LLC increased its stake in shares of Cerner by 6.5% in the second quarter. Gyroscope Capital Management Group LLC now owns 4,025 shares of the company’s stock valued at $268,000 after purchasing an additional 246 shares during the period. Finally, Frontier Wealth Management LLC increased its stake in shares of Cerner by 0.4% in the second quarter. Frontier Wealth Management LLC now owns 66,108 shares of the company’s stock valued at $4,394,000 after purchasing an additional 265 shares during the period. Hedge funds and other institutional investors own 81.83% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This article was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://www.americanbankingnews.com/2018/01/18/cerner-cern-research-coverage-started-at-evercore-isi.html.

About Cerner

Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.

Analyst Recommendations for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply